Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Comment on: Schnitzlers syndrome--exacerbation after anti-TNF treatment.

de Koning HD, van der Meer JW, Simon A.

Rheumatology (Oxford). 2007 Nov;46(11):1741 author reply 1741. No abstract available.

PMID:
17956920
2.

Schnitzler's syndrome--exacerbation after anti-TNF treatment.

Thonhofer R, Uitz E, Graninger W.

Rheumatology (Oxford). 2007 Jun;46(6):1041-2. Epub 2007 Apr 19. No abstract available.

PMID:
17449490
3.

Schnitzler's syndrome improvement after anti-TNF-alpha therapy.

Aikawa NE, Silva CA, Bonfá E, Carvalho JF.

Joint Bone Spine. 2010 Oct;77(5):491. doi: 10.1016/j.jbspin.2010.02.016. Epub 2010 May 15. No abstract available.

PMID:
20478726
4.

Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?

Gabriel SE.

Arthritis Rheum. 2008 Mar;58(3):637-40. doi: 10.1002/art.23280. No abstract available.

5.

New drugs for rheumatoid arthritis.

Olsen NJ, Stein CM.

N Engl J Med. 2004 May 20;350(21):2167-79. Review. No abstract available.

PMID:
15152062
6.

Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome.

de Koning HD, Schalkwijk J, van der Meer JW, Simon A.

J Allergy Clin Immunol. 2011 Dec;128(6):1352-4. doi: 10.1016/j.jaci.2011.05.023. Epub 2011 Jun 25. No abstract available.

PMID:
21704363
7.

Immunoglobulins during different treatment regimes in Schnitzler's syndrome.

Thonhofer R.

Rheumatol Int. 2011 Dec;31(12):1665-7. doi: 10.1007/s00296-010-1681-1. Epub 2010 Dec 2. No abstract available.

PMID:
21125280
8.

Anti-TNF-alpha therapies: they are all the same (aren't they?).

Mpofu S, Fatima F, Moots RJ.

Rheumatology (Oxford). 2005 Mar;44(3):271-3. Epub 2004 Nov 23. Review. No abstract available.

PMID:
15561736
10.

Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.

van der Stoep D, Braunstahl GJ, van Zeben J, Wouters J.

J Rheumatol. 2009 Dec;36(12):2847-8. doi: 10.3899/jrheum.090307. No abstract available.

PMID:
19966199
11.
12.

["MGUS": a potentially under diagnosed event during anti-TNF-α treatment of psoriasis?].

Schmutz JL, Trechot P.

Ann Dermatol Venereol. 2013 Feb;140(2):157-8. doi: 10.1016/j.annder.2012.12.010. Epub 2013 Jan 16. French. No abstract available.

PMID:
23395504
13.

Anakinra: an effective treatment in the Schnitzler syndrome.

Vandenhende MA, Bentaberry F, Morlat P, Bonnet F.

Joint Bone Spine. 2011 Dec;78(6):636-7. doi: 10.1016/j.jbspin.2011.03.021. Epub 2011 May 6.

PMID:
21550281
14.

[When are "biologics" indicated?].

[No authors listed]

MMW Fortschr Med. 2006 Apr 27;148(17):10. German. No abstract available.

PMID:
16711479
15.

Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

Listing J, Strangfeld A, Kekow J, Schneider M, Kapelle A, Wassenberg S, Zink A.

Arthritis Rheum. 2008 Mar;58(3):667-77. doi: 10.1002/art.23281.

16.

Tumor necrosis factor inhibitors for rheumatoid arthritis.

Scott DL, Kingsley GH.

N Engl J Med. 2006 Aug 17;355(7):704-12. Review. No abstract available.

PMID:
16914706
17.

Remission of Schnitzler syndrome after treatment with anakinra.

Frischmeyer-Guerrerio PA, Rachamalla R, Saini SS.

Ann Allergy Asthma Immunol. 2008 Jun;100(6):617-9. doi: 10.1016/S1081-1206(10)60064-6. No abstract available.

PMID:
18592830
18.

Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.

Hyrich KL, Silman AJ.

J Rheumatol. 2006 May;33(5):831-3. No abstract available.

PMID:
16652412
19.

Onset of psoriasis during treatment with TNF-{alpha} antagonists: a report of 3 cases.

Ubriani R, Van Voorhees AS.

Arch Dermatol. 2007 Feb;143(2):270-2. No abstract available.

PMID:
17310016
20.

[New treatments for rheumatoid arthritis].

Girault V, Flipo RM.

Soins. 2004 Sep;(688):37-8. French. No abstract available.

PMID:
15515847

Supplemental Content

Support Center